Literature DB >> 82551

Systemic (half-body) radiation therapy: response and toxicity.

O M Salazar, P Rubin, B Keller, C Scarantino.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 82551     DOI： 10.1016/0360-3016(78)90003-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  14 in total

Review 1.  Radiation dose-volume effects in the lung.

Authors:  Lawrence B Marks; Soren M Bentzen; Joseph O Deasy; Feng-Ming Spring Kong; Jeffrey D Bradley; Ivan S Vogelius; Issam El Naqa; Jessica L Hubbs; Joos V Lebesque; Robert D Timmerman; Mary K Martel; Andrew Jackson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

Review 2.  The role of radiation therapy in the treatment of metastatic castrate-resistant prostate cancer.

Authors:  Jim N Rose; Juanita M Crook
Journal:  Ther Adv Urol       Date:  2015-06

Review 3.  A survey of changing trends in modelling radiation lung injury in mice: bringing out the good, the bad, and the uncertain.

Authors:  Mohamad B Dabjan; Carolyn Ms Buck; Isabel L Jackson; Zeljko Vujaskovic; Brian Marples; Julian D Down
Journal:  Lab Invest       Date:  2016-08-01       Impact factor: 5.662

4.  A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients.

Authors:  P Bey; P M Wilkinson; M Resbeut; S Bourdin; O Le Floch; W Hahne; N Claverie
Journal:  Support Care Cancer       Date:  1996-09       Impact factor: 3.603

5.  A further comparison of pathologies after thoracic irradiation among different mouse strains: finding the best preclinical model for evaluating therapies directed against radiation-induced lung damage.

Authors:  Isabel L Jackson; Zeljko Vujaskovic; Julian D Down
Journal:  Radiat Res       Date:  2011-02-21       Impact factor: 2.841

6.  Prostate Cancer Old Problems and New Approaches. Part III. Prevention and Treatment.

Authors:  Kenneth V Honn; Amer Aref; Yong Q Chen; Michael L Cher; John D Crissman; Jeffrey D Forman; Xiang Gao; David Grignon; Maha Hussain; Arthur T Porter; J.Edson Pontes; Bruce Redman; Wael Sakr; Richard Severson; Dean G Tang; David P Wood
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

7.  Mast Cells Contribute to Radiation-Induced Vascular Hyperpermeability.

Authors:  Kyung Ran Park; Wayne L Monsky; Chang Geol Lee; Chang Ho Song; Dong Heui Kim; Rakesh K Jain; Dai Fukumura
Journal:  Radiat Res       Date:  2016-01-15       Impact factor: 2.841

8.  Do variations in mast cell hyperplasia account for differences in radiation-induced lung injury among different mouse strains, rats and nonhuman primates?

Authors:  Julian D Down; Meetha Medhora; Isabel L Jackson; J Mark Cline; Zeljko Vujaskovic
Journal:  Radiat Res       Date:  2013-07-02       Impact factor: 2.841

9.  Efficacy and safety of 3D-conformal half body irradiation in patients with multiple bone metastases.

Authors:  Gabriella Macchia; Milena Ferro; Savino Cilla; Milly Buwenge; Anna Ianiro; Mariangela Boccardi; Vincenzo Picardi; Marica Ferro; Eleonora Arena; Alice Zamagni; Silvia Cammelli; Vincenzo Valentini; Alessio G Morganti; Francesco Deodato
Journal:  Clin Exp Metastasis       Date:  2018-09-24       Impact factor: 5.150

10.  Revisiting strain-related differences in radiation sensitivity of the mouse lung: recognizing and avoiding the confounding effects of pleural effusions.

Authors:  Isabel L Jackson; Zeljko Vujaskovic; Julian D Down
Journal:  Radiat Res       Date:  2010-01       Impact factor: 2.841
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.